Monday, 5 August 2013

Global Evolving Market For Biosimilar Opportunities: Industry Shares , Growth, Trend And Research Analysis

The long awaited promise of biosimilars takes another step to fulfilment with the first approval in Europe of high-value second generation products. But what products can be expected to follow, who is developing them and what are the hot prospects?

Biosimilars: another milestone passed

At the end of June 2013, the European Medicines Agency’s Committee for Medical Products for Human Use issued a positive opinion for the first biosimilar version of Johnson & Johnson’s infliximab for the treatment of rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis. For the two successful applicants, Celltrion and Hospira, this development passes a significant milestone for the whole biosimilar sector as the products are the first monoclonal antibody (mAb) therapies to reach a positive opinion following review via the EMA biosimilars regulatory pathway. This is an important event which heralds a new era of lower-cost biological therapies in Europe.

For J&J and its partners, the news is less welcome. Already under pressure from branded competitors in the TNF inhibitor market, it is no surprise that both developer and biosimilar companies will be assessing what share they may secure of its US$6.13 billion revenues.

The tip of a US$41 billion iceberg

While significant for J&J, infliximab is just the tip of the iceberg when it comes to the potential for biosimilars. In terms of revenue, six of the top ten pharmaceutical therapies are biological products, which have been targeted by biosimilar developers: Abbvie’s Humira (adalimumab), Roche’s MabThera (rituximab), Herceptin (trastuzumab) and Avastin (bevacizumab), Sanofi’s Lantus (insulin glargine), and Johnson & Johnson’s Remicade (infliximab). These products had combined global sales of US$41.4 billion in 2012. Also of significant importance to biosimilar developers, with sales of US$4.2 billion in 2012 is Amgen’s Enbrel (etanercept).

To Buy A Copy Of This Report Visit Website:

Open season: Branded industry gets in on the act It may have taken a while, but the world’s major pharmaceutical originators have recognised the potential for biosimilars. A number have disclosed their intentions and/or announced clinical trials in recent months. For example, in February 2013, Amgen announced plans to launch a portfolio of six new biosimilars beginning in 2017: adalimumab, infliximab, bevacizumab, trastuzumab, rituximab and cetuximab. Four of these projects form part of the company’s development agreement with Actavis. In June 2012, Merck KGaA and Dr Reddy's Laboratories announced a partnership to co-develop a portfolio of biosimilar compounds in oncology, primarily focused on monoclonal antibodies. Pfizer has been openly active in generics and biosimilars for some time. The company previously had a collaborative deal with Biocon for its insulin products, although this deal was concluded in March 2012. In May 2013, Pfizer began a Phase I trial with an infliximab biosimilar, PF-06438179. Many smaller biosimilar developers have the ambition but not the resources. The increasing interest from big Pharma will bring a welcome boost of expertise and funding to research and partnering.

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Now Available China Wind Power Gear Box Filter Industry 2013

The report firstly introduced Wind Power Gear Box Filter basic information included Wind Power Gear Box Filter definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Wind Power Gear Box Filter industry policy and plan, Wind Power Gear Box Filter product specification, manufacturing process, product cost structure etc. then statistics China key manufacturers Wind Power Gear Box Filter capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Wind Power Gear Box Filter products customers application capacity market position Pallontact information etc company related information, then collect all these manufacturers data and listed China Wind Power Gear Box Filter capacity production capacity market share production market share supply demand shortage import export consumption etc data statistics, and then introduced China Wind Power Gear Box Filter 2009-2013 capacity production price cost profit production value gross margin etc information. 

And also listed Wind Power Gear Box Filter upstream raw materials equipments and down stream client survey analysis and Wind Power Gear Box Filter marketing channels industry development trend and proposals. In the end, this report introduced Wind Power Gear Box Filter new project SWOT analysis Investment feasibility analysis investment return analysis and also give related research conclusions and development trend analysis of China Wind Power Gear Box Filter industry. In a word, it was a depth research report on China Wind Power Gear Box Filter industry. And thanks to the support and assistance from Wind Power Gear Box Filter industry chain related technical experts and marketing engineers during Research Team survey and interviews.

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

New Release: Asia Pacific Renewable Energy Policy Handbook 2013

Asia-Pacific Renewable Energy Policy Handbook 2013” is the latest policy report from GlobalData, the industry analysis specialists that offer comprehensive information on major policies governing renewable energy market in the region.

The report presents an in-depth analysis of the renewable energy policies across the major countries in Asia-Pacific namely Australia, China, India, Japan, South Korea, Thailand, New Zealand, Vietnam and Taiwan. The report provides the current and future renewable energy targets and plans along with the present policy framework, giving a fair idea of overall growth potential of their renewable energy industry. The report also provides major technology specific policies and incentives provided in each of these countries. The report also provides insights to major policy initiatives for the market development of renewable energy sources such as wind, solar, geothermal, biopower and biofuels. 

The report is built using data and information sourced from industry associations, government websites and statutory bodies. The information is also sourced through other secondary research sources such as industry and trade magazines.

To Buy A Copy Of This Report Visit :


  • The report covers policy measures and incentives used by the major countries in Asia-Pacific to promote renewable energy.
  • The report details promotional measures in different countries both for the overall renewable energy industry and for specific renewable energy technologies namely solar, wind, geothermal, hydro and bioenergy.
  • The report also highlights the differences and focus of the renewable energy policy frameworks in different countries in Asia-Pacific.
  • The report provides a platform for comparison of various renewable energy policies across countries. Major countries include Australia, China, India, Japan, South Korea, Thailand, New Zealand, Vietnam and Taiwan.

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Finite Element Analysis Market in Thailand Singapore, Vietnam, Philippines, Malaysia, Indonesia 2012-2016

Finite Element Analysis (FEA) market in Thailand to grow at a high rate over the period 2012-2016. One of the key factors contributing to this market growth is the need to reduce the overall product development cost. The FEA market in Thailand has also been witnessing the development of collaborative FEA solutions. However, easy availability of open-source FEA software could pose a challenge to the growth of this market.

FEA Market in Thailand 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the FEA market in Thailand landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key questions answered in this report:

  • What will the market size be in 2016 and at what will be the growth rate?
  • What are key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by key vendors?
  • What are the strengths and weaknesses of each of these key vendors?


1. Executive Summary

2. Introduction

3. Market Coverage
Market Overview
Product Offerings

4. Market Landscape
4.1. Market Structure
4.2. Market Size and Forecast
4.3. Comparative Study
4.4. End-user Segmentation
4.5. Five Force Analysis

5. Vendor Landscape

6. Buying Criteria

7. Market Growth Drivers

8. Drivers and their Impact

9. Market Challenges

10. Impact of Drivers and Challenges

11. Market Trends

12. Key Vendor Analysis
12.1. Vendor 1
12.1.1. Business Overview
12.1.2. Business Segmentation
12.1.3. Key Information
12.1.4. SWOT Analysis
12.2. Vendor 2
12.2.1. Business Overview
12.2.2. Business Segmentation
12.2.3. Key Information
12.2.4. SWOT Analysis
12.3. Vendor 3
12.3.1. Business Overview
12.3.2. Business Segmentation
12.3.3. Key Information
12.3.4. SWOT Analysis
12.4. Vendor 4
12.4.1. Business Overview
12.4.2. Business Segmentation
12.4.3. Key Information
12.4.4. SWOT Analysis

13. Other Reports in this Series

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948